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Successful Treatment of Severe Metabolic Acidosis Due 
to Acute Aluminum Phosphide Poisoning With Peritoneal 
Dialysis 
A Report of 2 Cases
Bahman Bashardoust,1 Esmaeil Farzaneh,1 Afshin Habibzadeh,1 
Mir Salim Seyyed Sadeghi2 
Aluminum phosphide poisoning is common in our region. It can 
cause severe metabolic acidosis and persistent hypotension, which 
lead to cardiogenic shock and subsequently mortality. Oliguric 
or anuric acute kidney injury is seen in almost all patients with 
aluminum phosphide poisoning. Renal replacement therapies are 
recommended in these patients to improve metabolic acidosis 
and increase the rate of survival. We report 2 cases of severe 
acute aluminum phosphide poisoning treated successfully with 
peritoneal dialysis.
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INTRODUCTION
There is an increased report of self poisoning 
with aluminum phosphide tablets from Iran in 
recent years.1 Aluminum phosphide poisoning 
has a high mortality rate due to the absence of a 
specific antidote.2 Cardiogenic shock is the most 
important clinical feature, which is caused by 
direct myocardial toxicity of phosphine gas and 
severe metabolic acidosis.2-4 Different treatments 
are recommended in order to decrease the toxin 
absorption and to alkalize blood pH to prevent or 
improve the inevitable metabolic acidosis.5
Aggressive correction of metabolic acidosis could 
result in significant improvement in the patients’ 
outcome.6 Continuous renal replacement therapy 
is reported as an effective method of treating 
metabolic acidosis and increasing the survival.7 
However, peritoneal dialysis (PD) is not reported 
as a treatment modality for these cases. Here, we 
report successful treatment of 2 cases of intentional 
aluminum phosphide ingestion with PD. 
CASE REPORT
Two women aged 23 and 40 years old were 
admitted to the Emergency Department of Imam 
Khomeini Hospital of Ardabil after 30 minutes and 
3 hours ingestion of 1 tablet of 3 g of aluminum 
phosphide. The first patient had several vomiting 
episodes and the second patient presented with 
abdominal pain and multiple vomiting episodes. 
Both patients were tachypenic and hypotensive 
and had tachycardia with mild metabolic acidosis 
(Table). Severe metabolic acidosis occurred in the 
following hours and 19 and 10 vials of sodium 
bicarbonate were infused during the admission. 
We used an aggressive correction of acidosis 
protocol introduced by Jaiswal and colleagues6 to 
improve metabolic acidosis. During the treatment, 
the first patient had ventricular fibrillation and 
DC shock was given and later had ventricular 
tachycardia which was treated with amiodarone. 
Due to the severe metabolic acidosis and persistent 
hypotension regardless of fluid resuscitation and 
vasopressors in both cases, PD was initiated. We 
defined a new continuous PD protocol with the 
following setting: On the first day, 1000 mL every 
2 hours; on the second day, 1000 mL every 3 hours; 
and on the third to the last day of PD, 1000 mL 
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every 4 hours. Heparin, 500 units, intraperitoneal, 
was injected on the first day to the second day in 
every change and 1 time on the third day to the 
last day of PD. The PD was discontinued if kidney 
function, metabolic acidosis, and hemodynamic 
state were improved. Lactate-base peritoneal fluid 
was used for both patients. The PD fluid leaks or 
any complications were not seen during the PD. 
After 24 hours of successful PD in the first 
case, the metabolic acidosis was improved and 
the patient had normal ABG (Table) and normal 
hemodynamic state. On day 3, PD was stopped and 
the patient was discharged on day 5. The status 
of second case was improved in the first 8 hours 
of PD and during the next days, she had stable 
hemodynamics, normal blood pressure, and normal 
arterial blood gas, and the patient was discharged 
4 days after PD. 
DISCUSSION
There is no potent antidote for aluminum 
phosphide poisoning and supportive and critical 
care to balance blood pH, electrolytes, and 
arterial blood pressure is the main treatment 
approach.5 Most of the patients have low blood 
pressure refractory to inotropic support.6 Lower 
bicarbonate levels may require sodium bicarbonate 
intravenously in order to increase the bicarbonate 
level to 18 mEq/L to 20 mEq/L.8 It is shown that 
the correction of metabolic acidosis improves 
outcomes in aluminum phosphide poisoning.6 
Dialysis may be required for severe acidosis and 
acute kidney failure.8
We used PD as the main treatment along with 
conservative and routine treatments of aluminum 
phosphide poisoning in the treatment of severe 
metabolic acidosis and observed significant 
improvement in pH and bicarbonate levels of 
these patients. Both cases survived and were 
discharged from the hospital. We intended to 
treat both metabolic acidosis due to mitochondria 
dysfunction and lactic acidosis (hemodynamic 
impairment) by using PD.
There are few theories on how PD is effective 
in treating severe metabolic acidosis.  Main 
phys iopathology of  a luminum phosphide 
poisoning is cellular ischemia that results in multi-
organ failure, and persistent hypotension is the 
consequence of this process.8 Cellular ischemia, 
vasodilator, and free radicals release can expedite 
this process and lead to death. Peritoneal dialysis 
by improving acidosis and hypothetically removing 
these toxins may lead to restoration of various 
organ functions. 
T h e  p h o s p h i n e  g a s  i s  a b s o r b e d  b y  t h e 
gastrointestinal tract by simple diffusion and is 
mainly excreted by the kidneys and lungs.9 Removal 
of phosphine gas from the gastrointestinal tract 
especially before its absorption could be helpful. 
Although the levels of phosphine or its metabolites 
were not measured in the dialysate fluid in our 
cases, we also hypothesize that PD could remove 
phosphine gas, possibly through the diffusion of 
phosphine from the intestinal membrane to the 
dialysate fluid. 
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